Advancement of molecular targeted therapies in squamous cell carcinoma of head and neck / 国际肿瘤学杂志
Journal of International Oncology
; (12): 40-42,75, 2010.
Article
em Zh
| WPRIM
| ID: wpr-591185
Biblioteca responsável:
WPRO
ABSTRACT
Current reseach of molecular targeted therapies in squamous cell carcinoma of head and neck(SCCHN) is particularly active.As epidermal growth factor receptor(EGFR) signaling pathway and angiogenesis play a key role in the growth of SCCHN,EGFR with its downstream effectors and molecular factors implicated in the angiogenesis process,such as vascular endothelial growth factor and its receptors,represent the main targets of new therapeutic agents now.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of International Oncology
Ano de publicação:
2010
Tipo de documento:
Article